Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
spartalizumab
×
Clear all
Filters
3
NCT02403193
2022-01-12
AdenONCO
Palobiofarma SL
Phase 1
Completed
92 enrolled